Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

A weight-loss drug more effective than Ozempic ... risks for your personal health situation with your doctor. Tirzepatide typically costs around A$345 per month for the starting dose.

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial ...

Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the ...

Scientists from Yale and other institutions have discovered that tirzepatide, a drug approved to treat type 2 diabetes, may also be highly effective for weight loss in people with obesity. This ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from Fullerton Wellness had an unidentified "black particulate" floating in it.

Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound ...

A weight-loss drug more effective than Ozempic ... risks for your personal health situation with your doctor. Tirzepatide typically costs around A$345 per month for the starting dose.